Pharmacokinetics of Methadone in Cynomolgus Macaques

4423Neuraxial Drug Delivery: Past, Present and Future

Date: Friday, September 16, 2022
Time: 10:30 am PT
Duration: 30 Minutes
Track: Friday - Track 1
Room: Salon ABCD
Speaker: Amy Martunas
Moderator: Darcy Gagne

Introduction: Methadone, a synthetic opioid has gained popularity as an analgesic for surgical procedures as it provides a longer effective duration compared to common opioids for moderate to severe pain. Pharmacokinetic (PK) data in dogs and humans demonstrate therapeutic duration for 12-14 hours. This study investigates the pharmacokinetics of methadone at 2 dose levels in Cynomolgus Macaques for use as extended duration opioid for surgical procedures involving moderate to severe pain post-operatively.
Methods: 8 Mauritius origin Cynomolgus Macaques were administered 0.2mg/kg and 0.5 mg/kg methadone hydrochloride intramuscularly (IM) and plasma and urine collected at predetermined time points and analyzed. Average mean total plasma concentration at 15 minutes post-administration: 37.7ng/mL Average mean total plasma concentration at 8 hours: 4.48ng/mL
Results: After IM administration, 0.2 mg/kg dose terminal half-life was 3.61 hrs and in therapeutic range for 8 hours; 0.5 mg/kg dose terminal half-life was 21.3 hrs and in therapeutic range for a minimum of 12 hours. Time points between 12-16 hours should be considered to determine when levels begin to decrease (plan to investigate in future study)
Conclusion: Established dosing ranges and duration for Methadone in NHPs to effectively address moderate-severe pain. Half-life increases significantly at higher dose Based on clinical application, 0.5mg/kg Methadone can be effectively dosed in NHPs at 12 hour intervals for moderate-severe pain Doses may need to be adjusted for chronic administration due to cumulative effect

This is an archived event. Please log in with your member account to access these resources.



Share this event

View More From This Track